Dow Up 0.08% Nasdaq Down 0.30%

More On ADHXF

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Fennec Pharmaceuticals Inc. (ADHXF)

-Other OTC
0.76 0.00(0.00%) Sep 4, 3:11PM EDT
Prev Close:0.76
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:1.19
Beta:N/A
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:0.21 - 2.28
Volume:0
Avg Vol (3m):23,753
Market Cap:7.49M
P/E (ttm):9.16
EPS (ttm):0.08
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ADHXF

Comparison

Symbol% ChgMkt Cap
ADHXF 0.00%7.49M
AZNUp 0.76%94.37B
OXGNUp 3.67%46.79M
RHHBYDown 0.70%255.73B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Fennec Pharmaceuticals Inc., together with its subsidiaries, operates as a biopharmaceutical company with a portfolio of product candidates under development for use in the treatment of cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback